Caxton Associates LLP Invests $2.16 Million in Omega Healthcare Investors, Inc. $OHI

Key Points

• Caxton Associates LLP invested approximately $2.16 million to purchase 56,592 shares of Omega Healthcare Investors, indicating growing interest in the real estate investment trust.
• Several large investors are increasing their stakes in Omega Healthcare, including CoreCap Advisors, which raised its holdings by 177.3% during the fourth quarter.
• Analysts have raised their price targets for Omega Healthcare Investors, with consensus estimates now around $43.38, reflecting positive sentiment toward the company.

Caxton Associates LLP bought a new position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund bought 56,592 shares of the real estate investment trust's stock, valued at approximately $2,155,000.

Other large investors have also recently made changes to their positions in the company. NBC Securities Inc. bought a new stake in shares of Omega Healthcare Investors in the 1st quarter worth about $29,000. CoreCap Advisors LLC grew its holdings in Omega Healthcare Investors by 177.3% during the 4th quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock valued at $60,000 after purchasing an additional 1,009 shares during the last quarter. Park Square Financial Group LLC bought a new position in Omega Healthcare Investors during the 4th quarter valued at about $61,000. UMB Bank n.a. grew its holdings in Omega Healthcare Investors by 94.9% during the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after purchasing an additional 1,059 shares during the last quarter. Finally, Meeder Asset Management Inc. grew its holdings in Omega Healthcare Investors by 1,581.3% during the 1st quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust's stock valued at $96,000 after purchasing an additional 2,372 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company's stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director owned 18,654 shares of the company's stock, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.50% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Scotiabank upped their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a report on Thursday, August 28th. Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Royal Bank Of Canada upped their price target on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a report on Thursday, August 7th. Truist Financial upped their price target on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a report on Wednesday, September 3rd. Finally, Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $43.38.

Omega Healthcare Investors Price Performance

Omega Healthcare Investors stock opened at $43.37 on Tuesday. The stock has a market cap of $12.79 billion, a price-to-earnings ratio of 26.77, a price-to-earnings-growth ratio of 2.26 and a beta of 0.71. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $44.42. The firm has a 50-day moving average of $39.77 and a two-hundred day moving average of $38.09.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.32. The company had revenue of $235.60 million during the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm's quarterly revenue was up 11.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.2%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's payout ratio is 165.43%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.